Lung Cancer

Did you know?

Women’s health is an economic issue we can’t afford to ignore.

We Found:

If we invest $40 million in lung cancer research focused on women, we get $611 million in returns to our economy.

We Learned:

Lung cancer research focused on women is more than good science, it’s a good investment, with a 1,200% return. We improve quality of life, reduce healthcare costs, add back millions in labor productivity and save 22,700 years of life.

When we add just $40 million for lung cancer research focused on women we get large returns:

0
years of life added
0
years restored to our workforce
$ 0 million
added back in labor productivity

Pays for itself 12× over.

Generates nearly $611 million in returns to the economy.

Research focused on women brings a 1,200% return on investment.

Read the Research Brief:

THE WHAM REPORT: Societal Impact of Research Funding for Women’s Health in Lung Cancer

Without information on the potential return on investment for women’s health research, stakeholders lack a basis for altering research investments to improve knowledge of women’s health. In this report, the authors examine the societal cost impact of increasing research funding in lung cancer and find that investing in women’s health research yields benefits beyond investing in general research.

Read the Complete Technical Report:

THE WHAM REPORT: Societal Impact of Research Funding for Women’s Health in Lung Cancer

Stacy Pagos Haller, President and CEO, BrightFocus Foundation
Dr. Hadine Joffee, Founding Member and Lead Scientific Advisor to the WHAM Collaborative Executive Director, Mary Horrigan Connors Center for Women’s Health Research, Brigham and Women’s Hospital
Dr. Michelle Mielke, Associate Professor of Epidemiology and Neurology, Mayo Clinic Co-Director, Specialized Center for Research Excellence on Sex Differences, Mayo Clinic
Dr. Antonella Santuccione Chadha, PhD, Co-Founder, Women’s Brain Project Head Stakeholder Liaison, Alzheimer’s Disease, Biogen International Medical Manager, Alzheimer’s Disease, Roche Diagnostics Europe
Meryl Comer, Vice Chair and Global Chair, WHAM; Co-Founder, UsAgainstAlzheimers/ WomenAgainstAlzheimers; Chair, Global Alliance on Women’s Brain Health
JoAnn Manson, Michael and Lee Bell Professor of Women’s Health, Medicine, Harvard Medical School Co-Director, Women’s Health, Brigham and Women’s Hospital
Scroll to Top